The University of Pennsylvania School of Medicine has partnered with Medable, a provider of digital trials platform to accelerate patient enrollment and increase patient retention in the Light Treatment Effectiveness (LITE) study, which evaluates home versus office-based narrowband ultraviolet B phototherapy for the treatment of psoriasis.Phase 4 Pragmatic StudyMedable’s direct-to-patient app was selected for LITE, a Phase 4 pragmatic study that will enroll 1050 patients across 20-40 clinical
Read More
Clinical Trials | News, Analysis, Insights - HIT Consultant
Report: Precision Medicine Is Impossible Without AI and Machine Learning
Artificial intelligence (AI) and machine learning are driving a great deal of the healthcare innovation in precision medicine, according to a new Chilmark Research report. The report reveals achieving the full potential of precision medicine is impossible to realize without applying AI and machine learning. Specifically, leveraging advanced machine learning and deep learning technology can rapidly analyze large datasets that outperform clinicians and researchers. Precision Medicine: Making
Read More
MyHealthTeams Lands $9.44M to Expand Social Networks for Chronic Condition Communities
MyHealthTeams, a San Francisco, CA-based creator of the largest and fastest-growing social networks for people facing chronic health conditions raised $9.44 million in a Series B financing round led by strategic investor UCB, a global biopharmaceutical company. This financing brings total investment in MyHealthTeams to $26.84M, building on the company's Seed and Series A1, A2 and A3 rounds. Existing investors including Adams Street Partners, Qiming US Ventures, CVS Health, The Westly Group,
Read More
FDA Cancer OCE, Syapse Partner on Regulatory Use of Real-World Evidence (RWE)
Syapse and the U.S. Food and Drug Administration (FDA) Oncology Center of Excellence (OCE) have signed a multi-year Research Collaboration Agreement (RCA) focused on the use of real-world evidence (RWE) to support regulatory decision-making. Syapse and the OCE will work with stakeholders across the FDA to address key regulatory questions about testing and treatment patterns, dosing and safety, and outcomes in oncology, with a focus on precision medicine.Methods to Derive RWE From Multiple
Read More
Clinithink Integrates With Healthitx HIE to Facilitate Assessment of Pre-Trial Feasibility
Clinithink and Healthix – the largest public health information exchange (HIE) in the U.S. – are partnering on a program designed to leverage Healthix clinical data to facilitate assessment of pre-trial feasibility, ensuring the validity of protocol design. The new program aims to improve population health in New York City and Long Island by eventually making cutting-edge treatments available to patients.Healthix Data & Clinithink AI – A Blueprint for InsightWith health data of over 17
Read More
Medable Joins the American Heart Association’s Center for Health Technology & Innovation Innovators Network
Medable Inc., a provider of digitally-enabled and data-driven clinical trials, will join the American Heart Association’s Center for Health Technology & Innovation (the Center) Innovators Network. The Center is focused on building health-tech relationships to drive innovative and scalable solutions across the health continuum.American Heart Association’s Center for Health Technology & Innovation Innovators NetworkThe Center helps members of its Innovators Network in the healthcare
Read More
MedAnswers Raises $5M for Scientifically, Clinically Validated FertilityAnswers App
MedAnswers, a health tech company has raised $5 million in seed round funding led by Special Situations’ Life Sciences Innovation (LSI) Fund, managed by David Sable, with Viking Global Investors also participating. MedAnswers is leveraging technology, genetics and other health data to match those struggling to conceive to a curated network of fertility experts and solutions to help users conceive faster. The company is a graduate of the 7th cycle of Illumina Accelerator. FertilityAnswers AppThe
Read More
SHUH, Syapse to Build South Korea’s First Real-World Data Sharing Network for Precision Oncology Hospitals
SNUH and Syapse will collaboratively work towards building South Korea’s first real-world data-sharing network for leading precision oncology hospitals in the region. Syapse, a company accelerating precision medicine through insights derived from its global health system network, and Seoul National University Hospital (SNUH), a South Korea-based hospital, today announced that they have extended their partnership with a new multi-year agreement. As part of their partnership, SNUH and Syapse will
Read More
What Is The Upside of Establishing Extended Reality As A Medical Device?
XR stands for extended reality. Basically, it's an umbrella term covering the VR (virtual reality), AR (augmented reality), and MR (mixed reality) technologies. All three are already involved or will be involved in healthcare. In the very near future, you will be able to “swipe” between all three within an application. Different combinations of the technologies will be used to provide specific health benefits, eventually all within a single platform.
It is sometimes hard to explain to people
Read More
Stanford, Sutter Health to Explore Joint Cancer Care Services in East Bay
Stanford Health Care and Sutter Health have signed a letter of intent to explore opportunities to jointly provide cancer care for patients and their families in the East Bay region of the San Francisco/Oakland metropolitan area. The intent of the collaboration is to increase access to high-quality cancer care for patients as close to home as possible by building on the strength of Stanford’s leadership in cancer care and clinical research, the Stanford Medicine network and Sutter’s integrated
Read More
